Politics
Anvisa updates registrations of medical cannabis products
Suplicy reports benefits of medical cannabis during treatment
What changes after the final ruling on medical cannabis in Rio
Anvisa bans sale and advertising of cannabis products
New Anvisa RDC raises quality standards for laboratories testing cannabis in Brazil
09/01/2026Published in the Federal Official Gazette, RDC No. 1,039/2026 establishes good practice criteria, ISO 17025 accreditation, and accreditation rules within Reblas, directly impacting the quality control of medical cannabis and industrial hemp products.
SUS-SP records more than 33,000 Cannabidiol dispensations since 2024
08/13/2026Data presented by Rafael Cairê de Oliveira dos Santos during a public hearing of the Parliamentary Front for Medicinal Cannabis and Industrial Hemp at Alesp show the evolution of public care and the territorial expansion of treatments in the State of São Paulo.
Follow Live: Anvisa now debates review of RDC 327 and cultivation
02/04/2026Anvisa directors meet this Wednesday (28) to discuss the update of medicinal cannabis regulations; learn how to follow
Government invests nearly R$ 400,000 to analyze impact of STF decision on marijuana possession
10/06/2025Study will analyze if the distinction of 40 grams for users reduced incarceration and socio-racial inequality, evaluating the practical effects of the new drug policy